After 32 weeks, mice on a WD developed NASH, with characteristic pericentral fibrosis (Fig. 4A), increased serum alanine aminotransferase levels, and transcripts for Tnf‐α and Tgf‐β1 (Fig. 4B). Here, TGFB1 is linked to metabolic dysfunction-associated steatohepatitis.